Cite
HARVARD Citation
Mayer, I. et al. (2021). Randomized Phase III Postoperative Trial of Platinum-Based Chemotherapy Versus Capecitabine in Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy: ECOG-ACRIN EA1131. Journal of clinical oncology. 39 (23), pp. 2539-2551. [Online].